Agios Pharma Drops Sickle Cell Disease Drug After Phase 2 Data DisappointNews DeskJuly 21, 20260 Agios Pharmaceuticals is stopping development of a drug for sickle cell disease after mid-stage clinical data showed the molecule failed…